Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

20 de julho de 2022 atualizado por: University of Oklahoma

A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial

The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Descrição detalhada

Background: A cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials offer cessation resources but have low accrual rates. Digital outreach may improve accrual, but knowledge of how best to recruit smokers with recent diagnoses is limited.

Objective: This study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer.

Methods: From February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial.

Tipo de estudo

Intervencional

Inscrição (Real)

99

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

  • Estados Unidos
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • Jordan Neil

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Speak and understand English
  • A recent cancer diagnosis (within the past 24 months)
  • 18 years or older
  • Report any cigarette use within the past 30 days

Exclusion Criteria:

  • Do not speak or understand English
  • Have not been diagnosed with cancer within the past 24 months
  • Below the age of 18
  • Does not report any cigarette use within the past 30 days

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição fatorial
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Falso: Control
The control condition was a kernel message that included study information present in all conditions but did not include any of the message factors.
Comportamental: Control
Does not include any of the three message factors.
Experimental: Proximal x Cost x Loss
Message frame: proximal threats of smoking, cost of continued smoking, and loss of not participating in a tobacco treatment trial.
Comportamental: Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Comportamental: Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Comportamental: Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Experimental: Proximal x Cost x Gain
Message frame: proximal threats of smoking, cost of continued smoking, and gain of participating in a tobacco treatment trial.
Comportamental: Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Comportamental: Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Comportamental: Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Experimental: Proximal x Benefit x Gain
Message frame: proximal threats of smoking, benefits of quitting, and gain of participating in a tobacco treatment trial.
Comportamental: Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Comportamental: Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Comportamental: Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Experimental: Proximal x Benefit x Loss
Message frame: proximal threats of smoking, benefits of quitting, and loss of not participating in a tobacco treatment trial.
Comportamental: Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
Comportamental: Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Comportamental: Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Experimental: Distal x Cost x Gain
Message frame: distal threats of smoking, cost of continued smoking, and gain of participating in a tobacco treatment trial.
Comportamental: Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Comportamental: Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Comportamental: Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Experimental: Distal x Cost x Loss
Message frame: distal threats of smoking, cost of continued smoking, and loss of not participating in a tobacco treatment trial.
Comportamental: Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
Comportamental: Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Comportamental: Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Experimental: Distal x Benefit x Loss
Message frame: distal threats of smoking, benefits of quitting, and loss of not participating in a tobacco treatment trial.
Comportamental: Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
Comportamental: Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Comportamental: Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
Experimental: Distal x Benefit x Gain
Message frame: distal threats of smoking, benefits of quitting, and gain of participating in a tobacco treatment trial.
Comportamental: Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
Comportamental: Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
Comportamental: Distal
The first factor tested framing of the long-term, distal threat of continued smoking.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Difference in intent to talk to a physician about participating in a smoking cessation study between factors.
Prazo: Within 30 minutes
The main effect within each message factor level was examined using ANOVA and compared with the control condition.
Within 30 minutes

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Predictors of intent to talk to a physician about participating in a smoking cessation study.
Prazo: Within 30 minutes
Other message evaluation and effectiveness measures were collected and explored in a multivariable model predicting intent to talk to a physician.
Within 30 minutes

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

University of Oklahoma

Colaboradores

Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Tufts University

Investigadores

  • Investigador principal: Jordan Neil, Ph.D., TSET Health Promotion Research Center

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

11 de fevereiro de 2019

Conclusão Primária (Real)

1 de abril de 2019

Conclusão do estudo (Real)

2 de abril de 2019

Datas de inscrição no estudo

Enviado pela primeira vez

13 de julho de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

20 de julho de 2022

Primeira postagem (Real)

22 de julho de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de julho de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

20 de julho de 2022

Última verificação

1 de julho de 2022

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Outros números de identificação do estudo

  • 2018P002035

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Control

Pesquisar ensaios semelhantes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

CROs by country

CROs in Djibouti

Condições

Doenças Raras

Intervenções de drogas

Suplementos Alimentares

Patrocinador / Colaboradores

Localizações

3
Se inscrever